Table 3 Univariable and multivariable analysis of factors associated with PPCs after cytoreduction surgery for ovarian cancer patients

Age (Y)

0.99 (0.97–1.03)

0.948

BMI (kg m⁻²)

0.99 (0.91–1.08)

0.849

ASA grade

1.77 (0.87–3.59)

0.116

 Hypertension

1.52 (0.77–2.99)

0.224

 Diabetes

0.96 (0.36–2.53)

0.930

 Preoperative DVT

1.09 (0.33–3.61)

0.882

 Preoperative albumin (g L⁻¹)

0.92 (0.87–0.98)

0.006

 Preoperative hemoglobin (g L⁻¹)

1.01 (0.99–1.02)

0.588

 FEV₁ (L)

1.97 (0.51–7.63)

0.328

 Neo-adjuvant chemotherapy

0.49 (0.16–1.48)

0.206

 Intraoperative fluid infusion volume (L)

1.79 (1.39–2.29)

< 0.001

1.34 (1.01–1.77)

0.040

 Blood transfusion volume (L)

1.89 (1.32–2.70)

0.001

 Blood loss volume (L)

1.47 (1.14–1.89)

0.003

 Operation time (h)

1.81 (1.48–2.20)

< 0.001

Diaphragmatic surgery

< 0.001

 Electrocoagulation/cauterization

2.68 (0.85–8.45)

0.093

 DP/stripping

5.22 (2.32–11.75)

< 0.001

 DFTR with direct closure

12.20 (4.37–34.09)

< 0.001

 DFTR with patch

30.50 (11.27–82.57)

< 0.001

 Diameter size of diaphragmatic resection (cm)

1.31 (1.19–1.44)

< 0.001

1.16 (1.06–1.28)

0.002

 SCS

1.42 (1.29–1.57)

< 0.001

1.26 (1.13–1.42)

<  0.001

 FIGO stage

3.29 (1.96–5.51)

< 0.001

 Anesthesia means

1.43 (0.72–2.84)

0.304

 Postoperative albumin (g L^− 1)

0.89 (0.84–0.94)

< 0.001